• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Guangzhen,ZHANG Lei,LIU Qi,XIAO Jing.Comparison of the application systems of X-ray diffraction technology in different pharmacopoeias[J].Journal Of Pharmaceutical Research,2026,45(9):1047-1051[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 228times   Download 207次 QR Code for this article
Scan with your phone!
不同药典X射线衍射技术应用体系的比较
刘广桢1,张雷1,刘琦1,肖镜2
Font:Larger+|Default|Smaller-
(1.山东省食品药品检验研究院,山东省中药标准创新与质量评价工程实验室,工业和信息化部产业技术基础公共服务平台,山东 济南 250101;2.中国药品检定研究院,北京 102629)
摘要:
本文通过比较中美欧药典X射线衍射(XRD)技术应用体系,系统揭示了该技术在药品质量控制中的核心价值与标准发展逻辑。中美欧药典均收载粉末X射线衍射法,且均明确其在晶态物质定性与定量分析中的核心应用,形成了XRD法在药品质控中应用的统一基础规范,在晶型药物鉴别、矿物药石棉检查、药用辅料功能性质控等领域形成国际共识,体现了XRD法在药品质控中的核心价值。建议药典持续强化单晶法的理论引领作用,提升粉末法的工业适用性,推动技术融合与数据赋能,加快成熟场景的通则化、各论品种的精准化布局,完善数字化、智能化、全程化的X射线衍射标准体系。
关键词:  X射线衍射  《中国药典》  《美国药典》  《欧洲药典》
DOI:10.13506/j.cnki.jpr.2026.09.013
基金项目:国家重点研发计划项目(No.2023YFC3504102)
Received Date:June 05, 2026   Revision Date:July 19, 2026   Publication Date:September 30, 2026
Comparison of the application systems of X-ray diffraction technology in different pharmacopoeias
LIU Guangzhen1,ZHANG Lei1,LIU Qi1,XIAO Jing2
(1.Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM,Ministry of Industry and Information Technology Industrial Technology Infrastructure Public Service Platform,Shandong Institute for Food and Drug Control,Jinan 250101,China;2.National Institutes for Drug Control,Beijing 102629,China)
Abstract:
This paper systematically reveals the core value and standard development logic of X-ray diffraction technology in pharmaceutical quality control by comparing the application systems of the Chinese, U.S., and European pharmacopoeias. All three pharmacopoeias include the powder X-ray diffraction method and explicitly define its fundamental role in qualitative and quantitative analysis of crystalline substances, establishing unified foundational norms for XRD applications in pharmaceutical quality control. International consensus has been formed in areas such as crystal form identification of drugs, asbestos testing in mineral medicines, and functional property control of pharmaceutical excipients, demonstrating the core value of XRD in pharmaceutical quality control. It is recommended that pharmacopoeias continue to strengthen the theoretical leadership of the single-crystal method, enhance the industrial applicability of the powder method, promote technological integration and data empowerment, accelerate the standardization of mature applications and the precise layout of monograph varieties, and improve the digitalized, intelligent, and comprehensive X-ray diffraction standard system.
Key words:  X-ray diffraction  Chinese Pharmacopoeia  United States Pharmacopeia  European Pharmacopoeia
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.